STOCK TITAN

Runway Growth Finance (RWAY) Financials

RWAY NASDAQ
FY2025 annual
Revenue Not reported for FY2025
Net Income $34.0M -53.7% YoY
EPS (Diluted) $0.93 -50.8% YoY
Operating Cash Flow $186.3M +167.1% YoY
Market Cap $269.5M as of Oct 27, 2026
Price / Sales n/m no revenue reported
Price / Earnings 7.9x on $34.0M net income, FY2025
Price / Book 0.5x on $502.6M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 27, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the RWAY SEC filings page.

This page shows Runway Growth Finance Corp. (RWAY) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RWAY FY2025

The latest year shows a smaller, less leveraged balance sheet, while cash generation sharply outpaced reported earnings.

In FY2025, operating cash flow rose 167.1% while net income fell 53.7%, a divergence that makes earnings a poor shorthand for cash generation in that year. Operating cash flow reached 547.2% of net income as assets contracted 12.0%, indicating that balance-sheet movements materially shaped cash results.

Liabilities fell 17.6% and long-term debt fell 21.2%, showing that balance-sheet contraction was accompanied by deleveraging. Because assets also fell 12.0% while equity declined 5.8%, the improvement did not come from expanding shareholder capital.

FY2025 dividends paid were $51.4M against net income of $34.0M, so distributions exceeded that year's accounting earnings. In FY2024, dividends of $69.9M were below net income of $73.6M, making the latest distribution less closely matched to current-year earnings.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Runway Growth Finance Corp. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
5/6

Runway Growth Finance Corp. passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income
$27.2M
YoY+61.9%
QoQn/m

Runway Growth Finance Corp. reported $27.2M in net income in Q2 2026. This represents an increase of 61.9% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
$0.65
YoY+44.4%
QoQn/m

Runway Growth Finance Corp. earned $0.65 per diluted share (EPS) in Q2 2026. This represents an increase of 44.4% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Revenue

Not reported for Q2 2026.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt
$10.8M
YoY+81.7%
QoQ+368.5%

Runway Growth Finance Corp. held $10.8M in cash against $678.9M in long-term debt as of Q2 2026.

Shares Outstanding
42M
YoY+15.7%
QoQ-1.3%

Runway Growth Finance Corp. had 42M shares outstanding in Q2 2026. This represents an increase of 15.7% from the same quarter a year earlier. Against the prior quarter it is down 1.3%.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Return on Equity
5.4%
YoY+2.0pp
QoQ+13.4pp

Runway Growth Finance Corp.'s quarterly ROE was 5.4% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is up 2.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 13.4 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Net Margin

Not reported for Q2 2026.

Capital Allocation

None of these metrics is reported for Q2 2026.

RWAY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RWAY quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Interest Expense$13.0M+10.5%$10.5M+1.9%N/A$10.6M-6.6%$11.8M+8.3%$10.3M-5.3%N/A$11.4M+9.0%
Net Income$27.2M+61.9%-$34.8M-1965.9%N/A$8.0M-68.0%$16.8M+102.6%$1.9M-84.5%N/A$25.0M+69.0%
EPS (Basic)$0.65+44.4%-$0.96-2020.0%$0.21-71.6%$0.22-66.2%$0.45+114.3%$0.05-83.3%$0.74n/m$0.65+75.7%
EPS (Diluted)$0.65+44.4%-$0.96-2020.0%$0.21-71.6%$0.22-66.2%$0.45+114.3%$0.05-83.3%$0.74n/m$0.65+75.7%
Diluted Shares (Avg)42M+13.4%36M-3.2%N/A36M-5.6%37M-5.3%37M-7.5%N/A38M-5.2%

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Income Tax.

RWAY Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RWAY quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$1.2B+17.4%$904.9M-12.4%$960.1M-12.0%$963.3M-10.4%$1.0B-3.4%$1.0B+0.2%$1.1B+1.1%$1.1B+4.0%
Cash & Equivalents$10.8M+81.7%$2.3M-87.4%$18.2M+216.0%$7.9M+118.9%$6.0M-32.3%$18.4M+165.5%$5.8M+93.6%$3.6M-75.8%
Total Liabilities$719.8M+32.7%$466.7M-11.9%$475.1M-17.6%$473.8M-16.6%$542.4M-5.2%$529.6M+5.6%$576.5M+8.3%$568.2M+22.5%
Long-Term Debt$678.9M+31.6%$426.9M-13.3%$435.3M-21.2%$443.5M-18.2%$515.9M-6.0%$492.2M+3.4%$552.3M+8.3%$542.5M+23.0%
Total Equity$502.6M+0.7%$438.2M-12.9%$485.0M-5.8%$489.5M-3.5%$498.9M-1.5%$503.3M-4.9%$514.9M-5.9%$507.4M-11.1%
Retained Earnings-$82.9Mn/m-$96.4Mn/m-$49.9Mn/m-$56.3Mn/m-$51.4Mn/m-$55.1Mn/m-$43.5Mn/m-$57.2Mn/m

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities.

RWAY Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RWAY quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$194.3Mn/m$5.9M-91.9%$20.6M+48.5%$92.4M+256.6%-$297Kn/m$73.6M+7.2%$13.9Mn/m$25.9M-74.7%
Financing Cash Flow$202.9Mn/m-$21.8Mn/m-$10.4Mn/m-$90.5Mn/m-$12.1M-129.8%-$61.0Mn/m-$11.8M-123.7%-$31.1Mn/m
Dividends Paid$14.0M$11.9M$11.9M-20.2%$13.0M-25.0%N/AN/A$14.9M-19.8%$17.3M-4.8%
Share BuybacksN/AN/A$0-100.0%$4.4M-35.2%N/AN/A$5.8M$6.7M

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow.

RWAY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RWAY quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Return on Equity5.4%+2.0pp-7.9%-8.3ppN/A1.6%-3.3pp3.4%+1.7pp0.4%-1.9ppN/A4.9%+2.3pp
Return on Assets2.2%+0.6pp-3.9%-4.0ppN/A0.8%-1.5pp1.6%+0.8pp0.2%-1.0ppN/A2.3%+0.9pp
Debt-to-Equity1.35+0.3x0.970.0x0.90-0.2x0.91-0.2x1.030.0x0.98+0.1x1.07+0.1x1.07+0.3x
Liabilities-to-Equity1.43+0.3x1.060.0x0.98-0.1x0.97-0.2x1.090.0x1.05+0.1x1.12+0.1x1.12+0.3x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Current Ratio, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Runway Growth Finance Corp. RWAY FY2025 N/A $34.0M N/A $269.5M —
STELLUS CAPITAL INVESTMENT CORPORATION SCM FY2025 $97.8M $27.0M 27.7% $191.4M 61/100

Frequently Asked Questions

Is Runway Growth Finance Corp. profitable?

Yes, Runway Growth Finance Corp. (RWAY) reported a net income of $34.0M in fiscal year 2025.

What is Runway Growth Finance Corp.'s earnings per share (EPS)?

Runway Growth Finance Corp. (RWAY) reported diluted earnings per share of $0.93 for fiscal year 2025. This represents a -50.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

How much debt does Runway Growth Finance Corp. have?

As of fiscal year 2025, Runway Growth Finance Corp. (RWAY) had $18.2M in cash and equivalents against $435.3M in long-term debt.

Runway Growth Finance Corp. (RWAY) has a return on equity of 7.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Runway Growth Finance Corp. (RWAY) generated $186.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Runway Growth Finance Corp. (RWAY) had $960.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Yes, Runway Growth Finance Corp. (RWAY) spent $12.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Runway Growth Finance Corp. (RWAY) had 36M shares outstanding as of fiscal year 2025.

Runway Growth Finance Corp. (RWAY) had a debt-to-equity ratio of 0.90 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Runway Growth Finance Corp. (RWAY) had a liabilities-to-equity ratio of 0.98 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Runway Growth Finance Corp. (RWAY) had a return on assets of 3.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Runway Growth Finance Corp. (RWAY) trades at 7.9x earnings, its market capitalization divided by $34.0M net income, FY2025. The market capitalization is $269.5M as of Oct 27, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Runway Growth Finance Corp. (RWAY) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $269.5M as of Oct 27, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Runway Growth Finance Corp. (RWAY) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Back to top